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We describe a simple PCR-based method for the isolation of genomic DNA
that lies adjacent to a known DNA sequence. The method is based on the
directional cloning of digested genomic DNA into the multiple cloning site of a
pUC-based plasmid to generate a limited genomic library. The library is plated
onto a number of selective LA plates which are incubated overnight, and
recombinant plasmid DNA is then isolated from resistant colonies pooled from
each plate. PCR amplification is performed on the pooled recombinant plasmid
DNAs using primers specific for the pUC vector and the known genomic
sequence. The combination of efficient directional cloning and bacterial
transformation gives relative enrichment for the genomic sequence of interest
and generates a simple DNA template, enabling easy amplification by PCR.
Introduction
The polymerase chain reaction (PCR) is a powerful technique for highly specific
amplification of DNA defined by two flanking primers and has had a major impact
on many aspects of biology (1). In the past, one of the factors limiting its application
has been the requirement that both sequences flanking the DNA of interest must be
known to specify the primers to be used. A number of methods have since been
reported that overcome this limitation and allow PCR to be used to amplify DNA
outside a region of known sequence. The first protocol described, termed Inverse
PCR, involves digestion of the DNA to produce a fragment containing known
sequence, followed by circularization by intramolecular ligation (2). The resulting
circular template is then PCR amplified via the use of divergent primers which have
been designed to anneal within the region of known sequence. This method is only
suitable when the digested DNA can be monomerically circularised. In Capture
PCR, only one primer is derived from the known sequence, whereas the second
primer anneals to a linker which has been ligated to one end of the digested DNA
sample. The second primer is also biotinylated to enable isolation of subsequent
extension products on a streptavidin support (3). Ligation of a linker to allow the
use of a defined second primer is also the strategy employed in Ligation Mediated
PCR, which is a method that has been used to generate in vivo footprints of
transcription factors bound to DNA (4). In this case, the linkers are ligated to blunt
ends which have been generated by random chemical cleavage of the genomic DNA
template, followed by denaturation of and primer extension from a known sequence.
Two further methods rely on the use of less specific second primers: Restriction-
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Site PCR employs oligonucleotide primers specific for given restriction enzyme
recognition sequences, in conjunction with a specific primer derived from the known
DNA sequence (5), whereas Targeted Gene Walking is based on PCR initiation with
primers bearing only partial homology at the 3' end of the target sequence (6). The
disadvantage of this latter method is that it produces numerous non-specifically
amplified species in addition to the correct PCR product.
The protocol we present here is most similar to the method described by
Mizobuchi and Frohman 1993, called Rapid Amplification of Genomic DNA Ends
(RAGE) (7). Both approaches involve ligation of digested genomic DNA to plasmid
DNA. PCR primers are designed so that one is homologous to a known target region
in the genomic DNA sequence, and the other is homologous to a defined plasmid
sequence. By the RAGE method, cloning is accomplished via digestion of genomic
DNA with a single restriction endonuclease, and the products are ligated into the
linearized, phosphatased plasmid vector. PCR is performed directly on the ligated
DNA employing nested primers and two rounds of amplification to increase
specificity. In contrast, our method involves directional cloning of genomic DNA
into the multiple cloning site of a plasmid vector. The ligated products are then
transformed into bacteria and plated on selective media, and the plasmid DNA
recovered from the pool of surviving clones is PCR amplified. These additional
straight-forward steps give relative enrichment for the genomic sequence of interest
and generate a simple DNA template, enabling easy amplification by PCR.
Protocol
Required Reagents and Suggested Suppliers
Enzymes and Plasmids
Restriction enzymes (Boehringer Mannheim), T4 DNA Ligase (Boehringer
Mannheim), Taq Polymerase (Bioline). pUC18 (Boehringer Mannheim), pSL1180
(Pharmacia).
Other Reagents
Electroporation cuvettes, 2 mm gap (Biorad), Oligonucleotides: Universal primer
(pUC18) 5'ACACAGGAAACAGCTATGACCATG 3', TA Cloning Kit (Invitrogen).
Protocol
The basic steps in the protocol are outlined in Figure 1.
Digestion of Genomic and Plasmid DNA with Suitable Restriction Enzymes
1. Digest to completion 10 µg genomic DNA in a volume of 200 µl with 30 units
of the appropriate restriction enzymes, according to the manufacturer’s
instructions.
2. Digest to completion 1 µg plasmid DNA in a volume of 30 µl with suitable
restriction enzymes (i.e. enzymes which will allow directional cloning of the
inserts generated in step 1). Isolate the vector fragment away from the excised
polylinker by gel electroelution, phenol:chloroform extraction and ethanol
precipitation and resuspend in 20 µl sterile water.
Ligation of Genomic and Plasmid DNA
1. Set up the ligation with 300 ng genomic DNA and 50 ng plasmid vector in a
volume of 10 µl using 0.8 units T4 DNA ligase (Boehringer Mannheim) and
manufacturer’s ligation buffer. Incubate at 16°C overnight.
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Figure 1. A flow chart outlining the basic steps of the PCR-based protocol to isolate genomic  DNA
flanking a known DNA sequence.
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Electroporation and Plating of Transformed Bacteria
1. Ethanol precipitate the ligated DNA and resuspend in 5 µl sterile water.
2. Electroporate 2.5 µl of the ligation mix per 40 µl of electrocompetent Escherichia
coli, prepared according to Dower (8), using a Biorad Gene Pulser set at 200
µF, 25  and 2.4 kV  and electroporation cuvettes with a gap of 2 mm.
3. Add 1 ml SOC medium and allow bacteria to recover by shaking for 1 hour at
37°C.
4. Plate onto twelve 150 mm diameter LA plates containing 100 µg/ml ampicillin
and incubate overnight at 37°C.
Isolation of Plasmid DNA and Setting Up the PCR
1. Pool all of the ampicillin resistant (AmpR) colonies on each of the twelve plates,
add 10 mls SOC medium with 100 µg/ml ampicillin and shake for 4 hours at
37°C.
2. Spin down the cells at 4,000 rpm for 10 minutes and isolate the plasmid DNA
according to Sambrook et al. (9).
3. Set up the PCR reactions with 10 ng plasmid DNA and 25 pmol of each primer:
one specific for the known genomic sequence, and the other specific for the
vector (for example the universal primer if using pUC-based plasmids 5'
ACACAGGAAACAGCTATGACCATG 3'). Reaction volume is 50 µl,
containing 2 units of Taq polymerase and the buffer supplied by the manufacturer
(5 mM KCl, 1 mM Tris pH 7, 0.01 mg/ml gelatin, 3 mM MgCl2). The PCR
conditions used will depend on the specific set of primers and the size of fragment
to be amplified. In the experiment for which the protocol was developed (10)
these were: 95°C for 5 min followed by 93°C for 30 s, 65°C for 50 s, 70°C for
6 min, repeated three times; 93°C for 30 s, 64°C for 50 s, 70°C for 6 min, 93°C
for 30 s, 63°C for 50 s, 70°C for 6 min, 93°C for 30 s, 62°C for 50 s, 70°C for
6 min, 93°C for 30 s, 61°C for 50 s, 70°C for 6 min, 93°C for 30 s, 60°C for 50
s, 70°C for 6 min, repeated 30 times.
Isolation and Cloning of the PCR Product
1. Run the PCR reactions on a 0.8% agarose gel.
2. Isolate the PCR product of the expected size by electroelution and clone and/or
nucleotide sequence to characterize further. The PCR product can be cloned
using the TA Cloning Kit (Invitrogen); if a single product is obtained in the
PCR, it can be cloned directly, without the need for electroelution.
Notes and Tips
Digestion of Genomic and Plasmid DNA with Suitable Restriction Enzymes
There is no need to size select the genomic DNA after digestion, prior to ligation.
The use of two different restriction enzymes allows highly efficient directional
cloning, gives enrichment for the correct insert and precludes the need to phosphatase
the vector. The choice of plasmid will be influenced by the suitable restriction enzyme
sites identified by mapping the genomic locus. There are many pUC-based plasmids
available, including pSL1180 (Pharmacia) which has more than thirty different
restriction enzyme sites in its multiple cloning site. It is worthwhile to purify the
digested vector away from the excised part of the multiple cloning site, as this will
reduce background due to vector religation.
Electroporation and Plating of Transformed Bacteria
Prior to electroporation, it may be advantageous to digest the ligated DNA with an
enzyme whose site is absent from the target genomic insert and plasmid vector. This
will enrich the ligation mixture for plasmids containing the target insert by linearizing
any plasmids containing the restriction endonuclease site, as bacterial transformation
of linear DNA is extremely inefficient.
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Concluding Remarks
The method we describe provides a rapid and easy means to isolate genomic
sequences that lie adjacent to known DNA sequences. The strength of this protocol
lies in its simplicity, and in the selection steps which enrich for a specific region of
interest in a highly complex genome. Only a preliminary Southern blotting analysis
needs to be performed to obtain a simple map of the region flanking the piece of
known DNA. By using directional cloning, which is very efficient, there is no need
to size fractionate the genomic DNA, and enrichment for a particular genomic
sequence can be achieved by the use of suitable restriction enzymes. This enrichment
step is generally applicable, since the selection of appropirate restriction enzyme
sites is only limited by their presence in the multiple cloning site of the plasmid
vector; given that there are many plasmid vectors which have large multiple cloning
sites [for example, pSL1180 (Pharmacia)] this is generally not problematic. Finally,
the primers and template used in the PCR reaction can be selected so that specific
restriction enzyme sites are present at each end of the molecule, and these sites can
be chosen to be optimal for efficient cloning and PCR.
The ability to amplify DNA segments that lie outside the boundaries of known
sequence has a number of applications in molecular biology. These include walking
along genomic DNA to sequence regions upstream of cloned cDNAs, isolating
unknown stretches of contiguous genomic DNA, and identifying restriction sites
for mapping purposes and DNA footprint analysis. A further application is in cloning
genes by insertional mutagenesis, an approach that relies on the integration of foreign
DNA into the genome causing disruption of an endogenous gene, resulting in a
mutant phenotype (11). The disrupted gene can then be cloned by using the introduced
DNA as a molecular tag. This is a particularly powerful approach when combined
with transgenic mouse technology, since the consequences of the resulting mutation
can be studied within the context of the whole animal. The method we describe here
was originally developed for this application, and has been successfully used to
isolate genomic sequences flanking a retroviral vector integrated into the mouse
genome (10). The method has a number of advantages for cloning genomic DNA
disrupted by insertional mutagenesis. By choosing appropriate restriction enzymes,
it is possible to clone one particular insertion site if several exist for a given piece of
foreign DNA. Enrichment for a site of insertion can also be achieved if a rare
restriction enzyme site, such as Not I, is present in the foreign DNA used for the
mutagenesis experiment. As the same foreign DNA can be used in different insertional
mutagenesis experiments, the same primers and PCR conditions can be employed
to isolate different insertion sites; only the restriction enzymes used for digestion of
the genomic DNA need to be determined for each site.
Acknowledgements
We would like to acknowledge the support of the Lister Institute and the National
Kidney Research Fund. CAB is a Lister Institute Research Fellow.We are grateful
to Elsevier Science B.V., Amsterdam for permission to use data previously published
in reference Natarajan, D. and Boulter, C.A. 1995. Gene. 161: 195-198.
References
1. Mullis, K.B. and Faloona, F.A. 1987. Specific synthesis of DNA in vitro via a
polymerase-catalyzed chain reaction. Methods Enzymol. 155: 335-350.
2. Triglia, T., Peterson, M.G. and Kemp, D.J. 1988. A procedure for in vitro
amplification of DNA segments that lie outside the boundaries of known
sequence. Nucleic Acids Res. 16: 8186.
3. Lagerstrom, M.J., Parik, J., Malmgren, H., Stewart, J., Patterson, U. and
52   Boulter and Natarajan
Landegren, U. 1991. Capture PCR: Efficient amplification of DNA fragments
adjacent to a known sequence in human and YAC DNA. PCR Methods Applic.
1: 111-119.
4. Mueller, P.R. and Wold B. 1989. In vivo footprinting of a muscle specific
enhancer by Ligation Mediated PCR. Science. 246: 780-786.
5. Sarkar, G., Turner, R.T. and Bolander, M.E. 1993. Restriction-site PCR: A direct
method of unknown sequence retreival adjascent to a known locus by using
universal primers. PCR Methods Applic. 2: 318-322.
6. Parker, J.D., Rabinovitch, P.S. and Burmer, G.C. 1991. Targeted gene walking
polymerase chain reaction. Nucleic Acids Res. 19: 3055-3060.
7. Mizobuchi, M. and Frohman, L.A. 1993. Rapid amplification of genomic DNA
ends. Biotechniques. 15: 214-216.
8. Dower, W.J. 1988. Transformation of E.coli to extremely high efficiency by
electroporation. Mol. Biol. Rep. 5: 3-4.
9. Sambrook, J., Fritsch, E.F. and Maniatis, T. 1989. Molecular Cloning: A
Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor, New York.
10. Natarajan, D. and Boulter, C.A. 1995. Isolation of genomic sequences flanking
a retroviral insertion site using a novel PCR-based method. Gene. 161: 195-
198.
11. Meisler, M.H. 1992. Insertional mutation of “classical” and novel genes in
transgenic mice. Trends Genet. 8: 341-344.
